Skip to content

Bioequivalence study of the consumption of plant-derived processed product with anti-obesity in healthy adults

Bioequivalence study of the consumption of plant-derived processed product with anti-obesity in healthy adults - Bioequivalence study of plant-derived processed product in healthy adults.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020272
Enrollment
20
Registered
2016-01-20
Start date
2016-01-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Product code A-002(1day, 1time, 10g), washout(over 6days), product code A-001(1day, 1time, 10g) Product code A-001(1day, 1time, 10g), washout(over 6days), product code A-002(1day, 1time, 10g)

Sponsors

New Drug Research Center, Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)BMI>=23.0and<30.0 kg/m2 2)Age>=35 and<65 years old 3)Person who provides inforrned consent by a document

Exclusion criteria

Exclusion criteria: 1) individual with liver, kidney and heart disease, or disorder of respiration, endocrine, metabolism, nervous system, consciousness, or diabetes, or other diseases, 2) individual given surgery within 2 months before the trial, 3) medicine user for hyperglycaemia, lipidemia, or hypertension, 4) individual intakes supplements or the food for specific use of health authorized the government, 5) individual experienced unpleasant feeling during blood drawing, 6) individual donated 200 mL or more blood within 1 month before the trial, 7) heavy smoker (cigarettes>=21/day), 8) shiftworker, 9) individual plans bussiness trip for 10 consecutive days or more, 10) individual had allergy against any constituents in the test diet, 11) individual can not conform to record of daily diet for 6 days (3 days x 2 times), 12) individual cannot allow operator to consult his/her data of the past health check, 13) individual have already participated other clinical trial and will participate, 14) pregnant women or breast-feeding women, 15) individual who was judged ineligibles by clinician in this trial

Design outcomes

Primary

MeasureTime frame
AUC0-8hr and Cmax of postprandial triglyceride

Countries

Japan

Contacts

Public ContactShinpei Tomita

New Drug Research Center, Inc. Clinical Research Dept.

s-tomita@ndrcenter.co.jp0123-34-0412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026